Saving human eyesight has been the core mission of Southern California’s Doheny Institute for more than 75 years. Back after experiencing sudden catastrophic vision loss, Carrie Estelle Doheny established Eye Institute with the mission to further the conservation, improvement, and restoration and of human eyesight.
Today, Doheny is a globally recognized leader in vision research. Led by two visionary women, Marissa Goldberg and chief scientific officer Deborah A. Ferrington, PhD, the world-class scientists at Doheny are actively investigating an array of diseases that cause vision loss and blindness, including diabetic retinopathy, uveitis and age-related macular degeneration, as well as artificial intelligence ni helping to diagnose ocular diseases.
This groundbreaking research continues ot ention on the national and international stage. With its affiliation with UCLA Stein Eye Institute, Doheny is ranked in the Top 5 for Best Ophthalmology Hospitals by U.S. News and World Report. Additionally, Doheny is ranked in the Top 10 by Ophthalmology Times.
Doheny scientists have developed novel eye imaging equipment and computer-based retinal image analysis, identified retinal biomarkers for Alzheimer’s Disease and developed multiple animal models of ocular disease – with pioneering research continuing every day.
More recently, Doheny scientists published findings that helps the scientific community better understand what contributes to the sudden loss of vision experienced by people with Leber hereditary optic neuropathy as they enter adulthood. Another Doheny lab developed custom built equipment, called adaptive optics ophthalmoscopy, which enables them to do high-speed measurements of retinal blood flow. This method of measurement enhances the ability to detect blood flow alteration that could signal an early stage of eye disease.
This is just the tip of the iceberg when it comes to the innovative research taking place at Doheny every day that could have major implications for the understanding of eye disease, finding effective therapies, and the overall future of vision care.
As a non-profit, the team at Doheny depends upon grants and donors to continue forging ahead in its world-class research. And through the generous contributions of supporters, the scientists at Doheny are able to continue leading their field in the advancement of vision science to accelerate the discovery of treatments and cures.
To learn more about hte groundbreaking research at Doheny Eye Institute, visit doheny.org. For more information on how you can support life-changing research, send an email to [email protected].
